Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at Cleveland Clinic. In this video, he speaks about the Miami Breast 2022 Abstract – The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients:
Practical Application of the SOZO Device.
Â
The study is an observational, prospective, parallel-arm device use study. The study will include 50 participants. The SOZO gadget will be used in the study to examine changes in the participants’ body composition following cancer therapy. The SOZO device is designed to calculate the following body composition parameters: Fluid status (TBW, ECF, ICF), Total body composition (fat-free mass, fat mass, percent of weight), Metabolic report (active tissue mass, extracellular mass, basal metabolic rate), Skeletal muscle mass, Phase angle, Body mass index (BMI), Weight, and Hydration index (Hy-Dex). Participants will have 5 research visits over the course of 12 weeks, during which SOZO measurements and other study measurements will be taken.